Literature DB >> 31295467

Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer's disease-like pathology.

S Sarkar1, E B Engler-Chiurazzi1, J Z Cavendish1, J M Povroznik1, A E Russell1, D D Quintana1, P H Mathers2, J W Simpkins3.   

Abstract

Autosomal dominant Alzheimer disease (AD) is caused by rare mutations in one of three specific genes. This is in contrast to idiopathic, late-onset AD (LOAD), which has a more polygenetic risk profile and represents more than 95% of cases. Previously, we have demonstrated that increased expression of microRNA (miRNA)-34a (miR-34a) in AD brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity. Here we report the generation of a heterozygous, conditional miR-34a overexpression mouse (miR-34a+/-(TetR-TetO-miR-34a) Transgenic Mice). Doxycycline-treated mice of either sex exhibited profound behavioral impairment compared to untreated groups with only 1-2 months of over-expression of miR-34a. Cognitive impairment of individual mice in T- and Y-maze tasks correlated with elevated miR-34a expression in many parts of the brain including the hippocampus and prefrontal cortex, regions which are known to be involved in this task and implicated in LOAD dysfunction. Immunocytochemistry of brain sections from mice show high amyloid β and phosphorylated tau-specific staining in the hippocampus and cortex. Analysis of protein samples from these mice revealed that miR-34a targets specific genes involved in memory formation, amyloid precursor protein (APP) metabolism and phosphorylation-dephosphorylation of tau. Thus, our results suggest that the polygenetic dysfunction caused by miR-34a may occur in LOAD and disclose miR-34a as a potential therapeutic target. SIGNIFICANCE STATEMENT: Late-onset Alzheimer disease (LOAD) is associated with multiple gene alleles, a polygenetic profile of risk factors that is difficult to model in animals. Our approach to modeling LOAD was to produce a conditional over-expressing, miR-34a mouse using doxycycline-induction to activate expression. We observed that miR-34a over-expression results in a rapid cognitive impairment, associated with accumulation of intracellular Aβ and tau hyperphosphorylation in multiple brain regions. Targets for miR-34a, including ADAM10, NMDAR 2B, and SIRT1 RNAs, were profoundly reduced by miR-34a over-expression. Collectively, these results indicate that a rapid, profound cognitive decline and Alzheimer's disease neuropathology can be induced with miR-34a over-expression, suggesting that this animal model may represent a polygenetic risk factor model for LOAD.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  ADAM10; Late-onset Alzheimer’s disease; Memory-related behaviors; NMDAR 2B; SIRT1; Tau phosphorylation; miR-34a; microRNA; β amyloid

Year:  2019        PMID: 31295467      PMCID: PMC7014559          DOI: 10.1016/j.brainres.2019.146327

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  56 in total

Review 1.  Alzheimer's disease is a synaptic failure.

Authors:  Dennis J Selkoe
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

2.  Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominant-negative suppression.

Authors:  Junichiro Miake; Eduardo Marbán; H Bradley Nuss
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

3.  Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.

Authors:  Marta Cosín-Tomás; Anna Antonell; Albert Lladó; Daniel Alcolea; Juan Fortea; Mario Ezquerra; Albert Lleó; Maria José Martí; Mercè Pallàs; Raquel Sanchez-Valle; José Luís Molinuevo; Coral Sanfeliu; Perla Kaliman
Journal:  Mol Neurobiol       Date:  2016-09-08       Impact factor: 5.590

Review 4.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

5.  Open-field bheavior in the rat: what does it mean?

Authors:  V H Denenberg
Journal:  Ann N Y Acad Sci       Date:  1969-07-30       Impact factor: 5.691

6.  Locomotor speed control circuits in the caudal brainstem.

Authors:  Paolo Capelli; Chiara Pivetta; Maria Soledad Esposito; Silvia Arber
Journal:  Nature       Date:  2017-10-23       Impact factor: 49.962

7.  NR2A-Containing NMDARs in the Prefrontal Cortex Are Required for Working Memory and Associated with Age-Related Cognitive Decline.

Authors:  Joseph A McQuail; B Sofia Beas; Kyle B Kelly; Kailey L Simpson; Charles J Frazier; Barry Setlow; Jennifer L Bizon
Journal:  J Neurosci       Date:  2016-11-02       Impact factor: 6.167

8.  MicroRNA-34a regulates cardiac ageing and function.

Authors:  Reinier A Boon; Kazuma Iekushi; Stefanie Lechner; Timon Seeger; Ariane Fischer; Susanne Heydt; David Kaluza; Karine Tréguer; Guillaume Carmona; Angelika Bonauer; Anton J G Horrevoets; Nathalie Didier; Zenawit Girmatsion; Peter Biliczki; Joachim R Ehrlich; Hugo A Katus; Oliver J Müller; Michael Potente; Andreas M Zeiher; Heiko Hermeking; Stefanie Dimmeler
Journal:  Nature       Date:  2013-02-20       Impact factor: 49.962

9.  Ketamine: behavioral effects of subanesthetic doses.

Authors:  M M Ghoneim; J V Hinrichs; S P Mewaldt; R C Petersen
Journal:  J Clin Psychopharmacol       Date:  1985-04       Impact factor: 3.153

10.  Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase.

Authors:  Fan Yeung; Jamie E Hoberg; Catherine S Ramsey; Michael D Keller; David R Jones; Roy A Frye; Marty W Mayo
Journal:  EMBO J       Date:  2004-05-20       Impact factor: 11.598

View more
  16 in total

Review 1.  Dysregulated miRNAs in Progression and Pathogenesis of Alzheimer's Disease.

Authors:  Tania Arora; Vikash Prashar; Randeep Singh; Tushar Singh Barwal; Harish Changotra; Arti Sharma; Jyoti Parkash
Journal:  Mol Neurobiol       Date:  2022-07-22       Impact factor: 5.682

2.  Dendritic Spine and Synaptic Plasticity in Alzheimer's Disease: A Focus on MicroRNA.

Authors:  Edwin Estefan Reza-Zaldivar; Mercedes Azucena Hernández-Sápiens; Benito Minjarez; Ulises Gómez-Pinedo; Victor Javier Sánchez-González; Ana Laura Márquez-Aguirre; Alejandro Arturo Canales-Aguirre
Journal:  Front Cell Dev Biol       Date:  2020-05-05

Review 3.  microRNAs as Early Biomarkers of Alzheimer's Disease: A Synaptic Perspective.

Authors:  Dolores Siedlecki-Wullich; Alfredo J Miñano-Molina; José Rodríguez-Álvarez
Journal:  Cells       Date:  2021-01-09       Impact factor: 6.600

4.  miR-34a induces spine damages via inhibiting synaptotagmin-1 in depression.

Authors:  Li-Tao Yi; Ji-Xiao Zhu; Shu-Qi Dong; Cheng-Fu Li; Qiu-Ping Zhang; Jie Cheng; Qing Liu
Journal:  Neurobiol Stress       Date:  2020-07-22

Review 5.  Mitochondrial Dysfunction and Mitophagy Closely Cooperate in Neurological Deficits Associated with Alzheimer's Disease and Type 2 Diabetes.

Authors:  Sangita Paul; Debarpita Saha; Binukumar Bk
Journal:  Mol Neurobiol       Date:  2021-04-01       Impact factor: 5.590

Review 6.  Mitochondrial MicroRNAs in Aging and Neurodegenerative Diseases.

Authors:  Albin John; Aaron Kubosumi; P Hemachandra Reddy
Journal:  Cells       Date:  2020-05-28       Impact factor: 6.600

7.  Enhancing α-secretase Processing for Alzheimer's Disease-A View on SFRP1.

Authors:  Bor Luen Tang
Journal:  Brain Sci       Date:  2020-02-22

8.  Qingxin Kaiqiao Recipe Improves Cognitive Performance, Inhibits Apoptosis, and Reduces Pathological Deposits in APP/PS1 Double Transgenic Mice via the PI3K/Akt Pathway.

Authors:  Shi-Yi Lin; Tian-Qi Wang; Lu-Ting Xu; Xiao-Xiao Lai; Yan Shen; Jian-Wei Lin; Shi-Yu Gao; Hai-Yan Hu
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-28       Impact factor: 2.629

Review 9.  Molecular Level Insight Into the Benefit of Myricetin and Dihydromyricetin Uptake in Patients With Alzheimer's Diseases.

Authors:  Miaomiao Liu; Hong Guo; Zhongyuan Li; Chenghua Zhang; Xiaoping Zhang; Qinghua Cui; Jingzhen Tian
Journal:  Front Aging Neurosci       Date:  2020-10-23       Impact factor: 5.750

Review 10.  MicroRNA: A Key Player for the Interplay of Circadian Rhythm Abnormalities, Sleep Disorders and Neurodegenerative Diseases.

Authors:  Chisato Kinoshita; Yayoi Okamoto; Koji Aoyama; Toshio Nakaki
Journal:  Clocks Sleep       Date:  2020-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.